Clopidogrel vs. aspirin in the chronic maintenance period following percutaneous coronary intervention in high thrombotic and high bleeding risk patients:sub-analysis of the HOST-EXAM Extended study
Event:
ESC Congress 2023
Topic:
Pharmacotherapy
Session:
Optimal antithrombotic regimen after percutaneous coronary intervention in stable coronary artery disease